The Epstein-Barr Virus Regulome in Lymphoblastoid Cells (original) (raw)
Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells
Hufeng Zhou
Journal of Virology, 2020
View PDFchevron_right
Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth
Jon Aster, B. Zhao
Proceedings of the National Academy of Sciences, 2011
View PDFchevron_right
Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2
Hufeng Zhou
Proceedings of the National Academy of Sciences, 2013
View PDFchevron_right
An Atlas of the Epstein-Barr Virus Transcriptome and Epigenome Reveals Host-Virus Regulatory Interactions
Kevin Tsai
Cell Host & Microbe, 2012
View PDFchevron_right
The EBNA2-EBF1 complex promotes oncogenic MYC expression levels and metabolic processes required for cell cycle progression of Epstein-Barr virus-infected B cells
Lucas Wange
2021
View PDFchevron_right
Epstein-Barr Virus Nuclear Protein EBNA3A Is Critical for Maintaining Lymphoblastoid Cell Line Growth
ANDREW Cooper
Journal of Virology, 2003
View PDFchevron_right
Cellular expression profiles of Epstein-Barr virus-transformed B-lymphoblastoid cell lines
Ratakorn Srisuttee
Biomedical Reports, 2020
View PDFchevron_right
Transcription Profiling of Epstein-Barr Virus Nuclear Antigen (EBNA)-1 Expressing Cells Suggests Targeting of Chromatin Remodeling Complexes
Maria Masucci
PLoS ONE, 2010
View PDFchevron_right
Epstein–Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines
B. Gewurz
2011
View PDFchevron_right
Gene array identification of Epstein Barr virus-regulated cellular genes in EBV-converted Burkitt lymphoma cell lines
Martine Raphael
Laboratory Investigation, 2002
View PDFchevron_right
Functional Implications of Epstein-Barr Virus Lytic Genes in Carcinogenesis
Lee Yap
Cancers
View PDFchevron_right
Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
Troy Messick
Oncotarget, 2017
View PDFchevron_right
Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells
Kostas Paschos, Paul Kellam, Rachael Bashford-Rogers
View PDFchevron_right
EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus–infected B cells
Lucas Wange
Proceedings of the National Academy of Sciences
View PDFchevron_right
Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders
Jaap Middeldorp
Critical Reviews in Oncology/Hematology, 2003
View PDFchevron_right
Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis
Klaus Rajewsky
Proceedings of the National Academy of Sciences, 2020
View PDFchevron_right
Epstein-Barr virus nuclear antigen proteins deploy diverse mechanisms to bind the human genome
Redwanul Haque
View PDFchevron_right
Epstein-Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferation
Kenneth Kaye
Proceedings of the National Academy of Sciences of the United States of America, 2016
View PDFchevron_right
Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1)
Louise Showe
Virology Journal, 2010
View PDFchevron_right
Epstein-Barr Virus Nuclear Protein 3A Domains Essential for Growth of Lymphoblasts: Transcriptional Regulation through RBP-J /CBF1 Is Critical
ANDREW Cooper
Journal of Virology, 2005
View PDFchevron_right
Phosphorylation sites of Epstein-Barr virus EBNA1 regulate its function
Dick Burgess
Journal of General Virology, 2009
View PDFchevron_right
Epstein–Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth
Siu Chun Hung
Proceedings of the National Academy of Sciences, 2001
View PDFchevron_right
Genome Diversity of Epstein-Barr Virus from Multiple Tumour Types and Normal Infection
Lawrence Young
Journal of Virology, 2015
View PDFchevron_right
A Genome-Wide Integrative Genomic Study Localizes Genetic Factors Influencing Antibodies against Epstein-Barr Virus Nuclear Antigen 1 (EBNA-1)
Nikhil Dhurandhar
PLoS genetics, 2013
View PDFchevron_right
Epstein–Barr virus and oncogenesis: from latent genes to tumours
Lawrence Young
Oncogene, 2003
View PDFchevron_right
The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB
Hongzhuan Wu
Oncotarget, 2015
View PDFchevron_right
RESTRICTED EPSTEIN-BARR-VIRUS PROTEIN EXPRESSION IN BURKITT-LYMPHOMA IS DUE TO A DIFFERENT EPSTEIN-BARR NUCLEAR ANTIGEN-1 TRANSCRIPTIONAL INITIATION SITE
Elliott Kieff
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991
View PDFchevron_right
LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis
Fotis Asimakopoulos
Journal of Clinical Investigation, 2014
View PDFchevron_right
Repression of the Proapoptotic Cellular BIK/NBK Gene by Epstein-Barr Virus Antagonizes Transforming Growth Factor 1-Induced B-Cell Apoptosis
Eva Campion
Journal of Virology, 2014
View PDFchevron_right
Role of EBNA-3 Family Proteins in EBV Associated B-cell Lymphomagenesis
SHATADRU GHOSH ROY
Frontiers in Microbiology, 2016
View PDFchevron_right
Host Genetic Variants and Gene Expression Patterns Associated with Epstein-Barr Virus Copy Number in Lymphoblastoid Cell Lines
Astrid Gall, Paul Kellam, Charlotte Houldcroft
View PDFchevron_right
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection
Shannon Kenney
PLoS pathogens, 2018
View PDFchevron_right
Epstein-Barr Virus EBNA-3C Is Targeted to and Regulates Expression from the Bidirectional LMP-1/2B Promoter
Andrew Brooks
Journal of Virology, 2006
View PDFchevron_right
Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2
Sam Lin
Journal of virology, 2002
View PDFchevron_right
The Epstein–Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation
Kenneth Kaye
Proceedings of the National Academy of Sciences, 1997
View PDFchevron_right